Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
1224 | 2680 | 49.4 | 94% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | STAT3 | Author keyword | 133 | 22% | 20% | 525 |
2 | STAT5 | Author keyword | 19 | 20% | 3% | 87 |
3 | STAT | Author keyword | 16 | 15% | 4% | 100 |
4 | STAT5A | Author keyword | 15 | 49% | 1% | 23 |
5 | SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 3 | Author keyword | 14 | 21% | 2% | 59 |
6 | STAT1 | Author keyword | 12 | 15% | 3% | 74 |
7 | STAT5A B | Author keyword | 12 | 86% | 0% | 6 |
8 | STAT3 INHIBITORS | Author keyword | 11 | 78% | 0% | 7 |
9 | STAT5B | Author keyword | 10 | 40% | 1% | 19 |
10 | STAT3 INHIBITOR | Author keyword | 8 | 60% | 0% | 9 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | STAT3 | 133 | 22% | 20% | 525 | Search STAT3 | Search STAT3 |
2 | STAT5 | 19 | 20% | 3% | 87 | Search STAT5 | Search STAT5 |
3 | STAT | 16 | 15% | 4% | 100 | Search STAT | Search STAT |
4 | STAT5A | 15 | 49% | 1% | 23 | Search STAT5A | Search STAT5A |
5 | SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 3 | 14 | 21% | 2% | 59 | Search SIGNAL+TRANSDUCER+AND+ACTIVATOR+OF+TRANSCRIPTION+3 | Search SIGNAL+TRANSDUCER+AND+ACTIVATOR+OF+TRANSCRIPTION+3 |
6 | STAT1 | 12 | 15% | 3% | 74 | Search STAT1 | Search STAT1 |
7 | STAT5A B | 12 | 86% | 0% | 6 | Search STAT5A+B | Search STAT5A+B |
8 | STAT3 INHIBITORS | 11 | 78% | 0% | 7 | Search STAT3+INHIBITORS | Search STAT3+INHIBITORS |
9 | STAT5B | 10 | 40% | 1% | 19 | Search STAT5B | Search STAT5B |
10 | STAT3 INHIBITOR | 8 | 60% | 0% | 9 | Search STAT3+INHIBITOR | Search STAT3+INHIBITOR |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CONSTITUTIVE ACTIVATION | 95 | 19% | 16% | 442 |
2 | SIGNAL TRANSDUCER | 94 | 20% | 16% | 429 |
3 | TRANSCRIPTION 3 | 80 | 43% | 5% | 143 |
4 | SERINE PHOSPHORYLATION | 40 | 18% | 8% | 204 |
5 | SIGNAL TRANSDUCERS | 38 | 33% | 3% | 93 |
6 | ACTIVATED SIGNAL TRANSDUCER | 27 | 76% | 1% | 19 |
7 | MOLECULAR TARGETS | 26 | 19% | 4% | 120 |
8 | SUPPRESSES GROWTH | 23 | 35% | 2% | 53 |
9 | STAT3 | 22 | 11% | 7% | 189 |
10 | STAT3 ACTIVATION | 22 | 18% | 4% | 107 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
STATs in cancer inflammation and immunity: a leading role for STAT3 | 2009 | 942 | 153 | 43% |
The stats of cancer - New molecular targets come of age | 2004 | 1083 | 117 | 53% |
The JAK-STAT Pathway at Twenty | 2012 | 194 | 97 | 40% |
Targeting the STAT3 signaling pathway in cancer: Role of synthetic and natural inhibitors | 2014 | 32 | 279 | 46% |
Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment | 2007 | 560 | 119 | 44% |
JAK-STAT signaling: From interferons to cytokines | 2007 | 380 | 63 | 56% |
STATs: Transcriptional control and biological impact | 2002 | 1435 | 151 | 48% |
NF-kappa B and STAT3 - key players in liver inflammation and cancer | 2011 | 228 | 91 | 31% |
STATs in oncogenesis | 2000 | 1102 | 162 | 54% |
STAT proteins: From normal control of cellular events to tumorigenesis | 2003 | 347 | 102 | 73% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | ABT ZELLULARE SIGNALVERARBEITUNG | 5 | 63% | 0.2% | 5 |
2 | LEIBNIZ FOR UNGS MOL PHARMAKOL | 4 | 75% | 0.1% | 3 |
3 | MED PLANTS OURCE SCI ENGN | 4 | 75% | 0.1% | 3 |
4 | CHINESE MED PLANTS OURCE LINGNAN | 3 | 100% | 0.1% | 3 |
5 | NACHWUCHSGRP ZELLULARE SIGNALVERARBEITUNG | 3 | 100% | 0.1% | 3 |
6 | SIGNALING GRP STAT5 | 3 | 100% | 0.1% | 3 |
7 | BEAUTY AESTHET SCI | 2 | 67% | 0.1% | 2 |
8 | INTERNAL RELATED DERMATOL | 2 | 67% | 0.1% | 2 |
9 | MOL BIOMED CMB | 2 | 67% | 0.1% | 2 |
10 | UNIV BIOMODELS AUSTRIA BIAT | 2 | 67% | 0.1% | 2 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000153879 | TOFACITINIB//JAK3//CP 690 550 |
2 | 0.0000137600 | GRIM 19//OLFACTOMEDIN 4//GW112 |
3 | 0.0000137155 | SOCS//SOCS1//SOCS3 |
4 | 0.0000129628 | INTERFERON RECEPTOR//IFNAR2//IFNAR1 |
5 | 0.0000117387 | CARDIOTROPHIN 1//CARDIOTROPHIN//ERK 1 AND 2 |
6 | 0.0000101620 | UNIT IMMUNOMICROBIO ENVIRONM CARCINOGENESIS//ANTI INTERLEUKIN 6 ANTIBODY//AUTOCRINE AND PARACRINE LOOPS |
7 | 0.0000084651 | IRF 1//IRF 2//INTERFERON REGULATORY FACTOR 1 |
8 | 0.0000056268 | ONCOSTATIN M//LEUKEMIA INHIBITORY FACTOR//LEUKAEMIA INHIBITORY FACTOR |
9 | 0.0000050352 | HYPOTHALAMIC FACTORS//IL 6 MESSENGER RNA//INTRAUTERINE SURVIVAL |
10 | 0.0000045828 | CUCURBITACIN B//CUCURBITACINS//CUCURBITACIN D |